← Back to Clinical Trials
Recruiting NCT05829161

NCT05829161 Sensory Phenotypes of Autism Spectrum Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05829161
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Autism
Study Type OBSERVATIONAL
Enrollment 480 participants
Start Date 2020-01-01
Primary Completion 2028-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Months
Max Age N/A
Study Type OBSERVATIONAL
Interventions
no intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 480 participants in total. It began in 2020-01-01 with a primary completion date of 2028-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project plans to establish sensory phenotypes of a Taiwanese ASD cohort across lifespan, including variety of sensory modalities, sensory domains, and clinical correlates. Also, we will clarify the relationship between sensory phenotypes and social impairment by two specific sensory-social paradigms targeting eye gaze avoidance and social touch anxiety, as well as the atypical neural representation of ASD during eye gaze and viewing social touch by fMRI and EEG.

Eligibility Criteria

Aim#1 Inclusion Criteria: * Diagnosis of autism spectrum disorder Aim#2 and #3 ASD group: Inclusion Criteria: * Diagnosis of autism spectrum disorder * Age above 12-40 years old Exclusion Criteria: * No diagnosis of autism spectrum disorder * Pregnant woman * Metal implant in the body TD group: Inclusion Criteria: * No diagnosis of autism spectrum disorder * Age above 12-40 years old Exclusion Criteria: * History of major psychiatric disorders * Pregnant woman * Metal implant in the body

Contact & Investigator

Central Contact

Yi Ling Chien

✉ ylchien@hotmail.com

📞 886-2-2312-3456

Principal Investigator

Yi Ling Chien

PRINCIPAL INVESTIGATOR

National Taiwan University Hospital

Frequently Asked Questions

Who can join the NCT05829161 clinical trial?

This trial is open to participants of all sexes, aged 18 Months or older, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05829161 currently recruiting?

Yes, NCT05829161 is actively recruiting participants. Contact the research team at ylchien@hotmail.com for enrollment information.

Where is the NCT05829161 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT05829161 clinical trial?

NCT05829161 is sponsored by National Taiwan University Hospital. The principal investigator is Yi Ling Chien at National Taiwan University Hospital. The trial plans to enroll 480 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology